Cephacare flavour 500 mg tablets for dogs
Cephacare flavour 500 mg tablets for dogs
Authorised
- Cefalexin monohydrate
Product identification
Medicine name:
Cephacare flavour 500 mg tablets for dogs
Cephacare Flavour 500 mg Comprimé
Active substance:
- Cefalexin monohydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefalexin monohydrate525.91/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- Cephacare flavour 500 mg tablets are supplied in PVC/aluminium foil blister packs each containing 10 tablets, in cardboardboxes containing 20 tablets.
- Cephacare flavour 500 mg tablets are supplied in PVC/aluminium foil blister packs each containing 10 tablets, in cardboardboxes containing 100 tablets.
- Cephacare flavour 500 mg tablets are supplied in PVC/aluminium foil blister packs each containing 10 tablets, in cardboardboxes containing 250 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
- Produlab Pharma B.V.
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 925/09/03/0977
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0454/003
Concerned member states:
-
Austria
-
Belgium
-
France
-
Germany
-
Luxembourg
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
